PT Bundamedik Tbk (IDX:BMHS)

PT Bundamedik Tbk Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1,614,341	1,554,685	1,488,197	1,658,688	1,890,800
Revenue Growth (YoY)	3.84%	4.47%	-10.28%	-12.28%	64.68%
Cost of Revenue	869,848	866,846	813,590	915,848	942,939
Gross Profit	744,492	687,839	674,607	742,840	947,861
Selling, General & Admin	628,563	586,546	581,369	415,685	405,196
Other Operating Expenses	26,050	13,340	5,530	2,196	-3,721
Operating Expenses	654,613	599,885	586,899	526,419	472,885
Operating Income	89,879	87,953	87,709	216,422	474,976
Interest Expense	-67,527	-64,703	-53,290	-42,694	-20,031
Interest & Investment Income	-	18,641	8,424	8,363	10,178
Other Non Operating Income (Expenses)	22,931	-3,350	-4,473	-4,425	-7,984
EBT Excluding Unusual Items	45,283	38,541	38,369	177,665	457,139
Gain (Loss) on Sale of Assets	-	52.94	1,954	-874.84	-
Pretax Income	45,283	38,594	40,323	176,790	457,139
Income Tax Expense	15,610	19,698	24,094	47,858	102,490
Earnings From Continuing Operations	29,673	18,896	16,229	128,932	354,649
Minority Interest in Earnings	-17,254	-6,952	-8,768	-45,704	-140,160
Net Income	12,419	11,944	7,461	83,228	214,489
Net Income to Common	12,419	11,944	7,461	83,228	214,489
Net Income Growth	3.98%	60.08%	-91.03%	-61.20%	141.57%
Shares Outstanding (Basic)	8,871	8,603	8,603	8,603	8,603
Shares Outstanding (Diluted)	8,871	8,603	8,603	8,603	8,603
Shares Change (YoY)	3.11%	-	-	-	314.14%
EPS (Basic)	1.40	1.39	0.87	9.67	24.93
EPS (Diluted)	1.40	1.39	0.87	9.67	24.93
EPS Growth	0.85%	60.08%	-91.03%	-61.20%	-41.67%
Free Cash Flow	31,716	-202,046	-157,915	-170,646	51,263
Free Cash Flow Per Share	3.58	-23.48	-18.36	-19.84	5.96
Dividend Per Share	-	0.650	0.560	1.500	2.557
Dividend Growth	-	16.07%	-62.67%	-41.34%	-
Gross Margin	46.12%	44.24%	45.33%	44.79%	50.13%
Operating Margin	5.57%	5.66%	5.89%	13.05%	25.12%
Profit Margin	0.77%	0.77%	0.50%	5.02%	11.34%
Free Cash Flow Margin	1.97%	-13.00%	-10.61%	-10.29%	2.71%
EBITDA	185,480	183,039	182,468	306,066	537,580
EBITDA Margin	11.49%	11.77%	12.26%	18.45%	28.43%
D&A For EBITDA	95,601	95,085	94,759	89,644	62,604
EBIT	89,879	87,953	87,709	216,422	474,976
EBIT Margin	5.57%	5.66%	5.89%	13.05%	25.12%
Effective Tax Rate	34.47%	51.04%	59.75%	27.07%	22.42%
Advertising Expenses	-	25,315	26,906	31,959	33,182

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.